-
IFA 2020 to physically take place, minus public accessIndustryMay 19, 2020The opening keynote for this year’s IFA will be delivered by Cristiano Amon, the president of Qualcomm. Amon will touch upon the topic of new normal after COVID-19 and the future of mobile connectiv... -
Shift of roster among listed biopharma firms in Q1IndustryMay 19, 2020Major tectonic shifts were noticed in the rankings of top 10 South Korean biologics and pharmaceutical firms in the first quarter this year, according to latest data Tuesday. Almost every company ha... -
Samsung Biologics’ 3rd plant gets business continuity certificateIndustryMay 19, 2020Samsung Biologics, the world’s largest contract development and contract manufacturing organization for biologics drugs, said Tuesday that its third plant complies with international standards for bu... -
GC Pharma will give COVID-19 plasma treatment away for freeIndustryMay 18, 2020GC Pharma said Monday that it would give out its blood plasma-derived COVID-19 treatment for free to domestic patients. The company’s pipeline, GC5131A, is currently under development and mass distr... -
Genexine consortium develops COVID-19 vaccine for human testingIndustryMay 18, 2020Korean biotech firm Genexine’s COVID-19 deoxyribonucleic acid vaccine pipeline GX-19 is ready for clinical testing, as soon as it applies to the Drug Ministry for human testing. Binex, which is part... -
Gates Foundation gives $3.6m to SK Bioscience’s COVID-19 researchIndustryMay 18, 2020Bill & Melinda Gates Foundation is doling out a series of funding for epidemic countermeasure research in Korea. SK Bioscience, a vaccine researcher and developer firm, said Monday that it has nabbe... -
KT gets Bill & Melinda Gates Foundation's W12b funding for epidemic researchIndustryMay 17, 2020Korean telecommunications firm KT will research for epidemic preparedness solutions, backed with 12 billion won ($9.7 million) in funding from the Bill & Melinda Gates Foundation. KT said Sunday tha... -
![[Weekender] Tightrope walk between hair regrowth and side effects](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2020/05/15/20200515000158_0.jpg)
[Weekender] Tightrope walk between hair regrowth and side effectsIndustryMay 16, 2020“I’ve been told about the possible adverse reactions of finasteride, but I still take it because I know the percentage of men who become impotent are only a fraction,” said Kang Si-hoon, a 33-year-ol... -
Hanmi may sue Sanofi for withdrawing from diabetes drug researchIndustryMay 14, 2020South Korea’s Hanmi Pharmaceutical may consider legal action against global biopharma Sanofi, as the French company abruptly decided to halt participation in further research on efpeglenatide, a pot... -
Seegene’s net profit jumps 600% in Q1IndustryMay 14, 2020Real-time polymerase chain reaction COVID-19 detection test kit maker Seegene saw a whopping 600 percent jump in its consolidated operating profit and net profit in the first quarter of 2020, accord... -
Bio Korea 2020 goes online amid pandemicIndustryMay 14, 2020Some of the topics that will be discussed in this year’s Bio Korea 2020 include electroceuticals for central nervous diseases, growing role of artificial intelligence in healthcare, Alzheimer’s disea... -
![[News Focus] Korean pharmas push for human test for COVID-19 drugs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2020/05/13/20200513000699_0.jpg)
[News Focus] Korean pharmas push for human test for COVID-19 drugsIndustryMay 13, 2020Optimistic timelines regarding the pharmaceutical race to produce a drug for COVID-19 have been met with skepticism, but even doubters do not deny that a vaccine or a treatment is desperately needed.... -
Empty duty-free stores hurt Hugel’s Q1 reportIndustryMay 13, 2020The drastic fall in duty-free shopping amid the ongoing global pandemic has eroded some 6 billion won ($4.9 million) from aesthetic solution company Hugel’s cosmetics product revenue. Hugel’s first-... -
Celltrion’s MERS, COVID-19 anti-virals selected as national projectsIndustryMay 13, 2020Celltrion announced Wednesday its anti-viral pipelines development for Middle East respiratory syndrome and COVID-19 have been selected as national projects. The Korea Health Industry Development In... -
SK Biopharmaceutical launches Xcopri in USIndustryMay 12, 2020SK Biopharmaceutical is tapping the 4 trillion won ($3.2 billion) US antiepileptic drug market with Xcopri, the company said Tuesday. Xcopri, the company’s brand of cenobamate tablets, is the produc...
MOST POPULAR
-
01Level 2 social distancing extended for another week
-
New virus cases under 100 for 2nd day; untraceable cases still hurdle in virus fight02
-
03[News Focus] High-profile DUI cases spur fresh crackdown
-
[News Focus] South Korea aging 2nd-fastest in OECD since 200004
-
05[Newsmaker] Offline classes to resume in Seoul schools from Monday
-
Moon is a big BTS fan: Cheong Wa Dae06
-
07Students in greater Seoul return to school as virus slows, learning gap widens
-
New virus cases at more than 1-month low; nationwide virus curbs extended again08
-
09Defector caught trying to cross back into N. Korea
-
[Newsmaker] How '70s oil shock led to SK battery biz10